Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer.

No abstract is available for this paper.

• Publication year

  1975

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  1975-03-15

• Fields of study

  Medicine

• Identifiers
  PMID 1092171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aortic lymph node metastases in early ovarian cancer.

  1974cited by this paper
• Histologic differences in breast carcinoma of Japanese and American women

  1974cited by this paper
• Prognostic significance of regional lymph node histology in uterine cervical cancer

  1973cited by this paper
• The Biologic Behavior of Low‐Grade Papillary Serous Carcinoma of the Ovary

  1972cited by this paper
• Factors affecting survival of patients with endometrial adenocarcinoma.

  1970cited by this paper
• Correlation of histologic grading with 5-years survival rates in endometrial carcinoma.

  1967cited by this paper
• Ovarian carcinoma. The problems of staging and grading.

  1966cited by this paper
• Nuclear structure in cancer tissues.

  1957cited by this paper
• NUCLEAR VARIABILITY IN HUMAN NEOPLASTIC CELLS

  1956cited by this paper

• Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer

  2023cites this paper
• Dedifferentiated and undifferentiated ovarian carcinoma: an aggressive and molecularly distinct ovarian tumor characterized by frequent SWI/SNF complex inactivation.

  2023cites this paper
• PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients

  2022cites this paper
• Expression and clinical significance of lncRNA BC041954 in ovarian cancer.

  2022cites this paper
• Microfibril Associated Protein 5 (MFAP5) Is Related to Survival of Ovarian Cancer Patients but Not Useful as a Prognostic Biomarker

  2022cites this paper
• Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer

  2020cites this paper
• Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer.

  2018cites this paper
• Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer

  2018cites this paper
• Prognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cells.

  2017cites this paper
• The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome

  2016cites this paper
• Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival

  2016cites this paper
• The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients

  2015cites this paper
• Gene Expression Analysis in Ovarian Cancer – Faults and Hints from DNA Microarray Study

  2014cites this paper
• p19INK4d mRNA and protein expression as new prognostic factors in ovarian cancer patients

  2013cites this paper
• High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.

  2012cites this paper
• Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

  2011cites this paper
• SIGNIFICANCE OF THE LYMPHOID STROMA AT THE INFILTRATIVE MARGIN ON THE ESOPHAGEAL CANCER

  2010cites this paper
• PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients

  2009cites this paper
• Analysis of selected molecular and clinical factors in patients with ovarian cancer treated with taxanes and cisplatin

  2008influential citation
• Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer

  2008cites this paper
• Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.

  2008cites this paper
• Variable CT Findings of Epithelial Origin Ovarian Carcinoma According to the Degree of Histologic Differentiation

  2007cites this paper
• CHFR gene is neither mutated nor hypermethylated in ovarian cancer.

  2007cites this paper
• Analiza wybranych czynników molekularnych i klinicznych u pacjentek leczonych z powodu raka jajnika taksanami i cisplatyną

  2006cites this paper
• Diagnosis and staging of ovarian cancer

  2004cites this paper
• TP53 status determines clinical significance of ERBB2 expression in ovarian cancer

  2004cites this paper
• Combination chemotherapy with epirubicin and cisplatin in ovarian carcinoma

  2004cites this paper
• Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen

  2003cites this paper
• P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.

  2003cites this paper
• P 21 WAF 1 , P 27 KIP 1 , TP 53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens

  2003cites this paper
• Absence of Estrogen Receptor-&agr; Expression in Human Ovarian Clear Cell Adenocarcinoma Compared With Ovarian Serous, Endometrioid, and Mucinous Adenocarcinoma

  2001cites this paper
• Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction

  2000cites this paper
• Tumor Infiltration by Monocytes and the Antitumor Effects of Monocyte Chemoattractant Protein-1

  1999cites this paper
• Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system.

  1998cites this paper
• Prognostic factors in ovarian cancer.

  1998cites this paper
• FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.

  1994cites this paper
• Staging Ovarian Cancer

  1993cites this paper
• Histologic, Nuclear, and Stromal Grading

  1993cites this paper
• Histologic Classification of Ovarian Tumors

  1993cites this paper
• Low Malignant Potential Ovarian Tumors: Borderline Ovarian Tumors

  1993cites this paper
• Prognostic factors and adjuvant treatment in early epithelial ovarian cancer

  1992cites this paper
• Prognostic factors in ovarian cancer.

  1992cites this paper
• Prognostic factors in ovarian cancer.

  1992cites this paper
• The prognostic value of image analysis in ovarian cancer

  1991cites this paper
• Histochemical distribution of CA-125 as a prognostic indicator in patients with serous ovarian cancer

  1991cites this paper
• Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma.

  1991cites this paper
• Endocrine factors in common epithelial ovarian cancer.

  1991cites this paper
• Correlation between tumor histology, steroid receptor status, and adenosine deaminase complexing protein immunoreactivity in ovarian cancer.

  1990cites this paper
• Primary ovarian transitional cell carcinoma. Diagnostic and prognostic considerations.

  1990cites this paper
• Protooncogene amplification and tumor ploidy in human ovarian neoplasms.

  1990cites this paper
• Ovarian Pathology

  1989cites this paper
• Cancer of the Ovary

  1989cites this paper
• General principles of grading lesions in diagnostic histopathology.

  1989cites this paper
• Prognostic significance of pathologic features of ovarian carcinoma.

  1989cites this paper
• A new histologic grading index in ovarian carcinoma.

  1989cites this paper
• Survival time, causes of death, and tumor/treatment-related morbidity in 100 women with ovarian cancer.

  1988cites this paper
• Ovarian cancer (review). Etiology, diagnosis, prognosis, surgery, radiotherapy, chemotherapy and endocrine therapy.

  1988cites this paper
• Changes in the Histocytological Grading of Epithelial Ovarian Carcinoma Following Treatment

  1988cites this paper
• Prognostic significance of dna index, multiploidy, and S‐phase fraction in ovarian cancer

  1988cites this paper
• DNA Ploidy Level and Cell Cycle Distribution in Ovarian Cancer: Relation to Histopathological Features of the Tumor

  1988cites this paper
• Neutral mucosubstances as a prognostic indicator in serous and endometrioid carcinomas of the ovary. A morphometrical analysis of saliva‐periodic acid‐Schiff stain

  1986cites this paper
• Periodic acid‐Schiff stain as a prognostic indicator in serous and mucinous ovarian tumors

  1986cites this paper
• Prognostic factors in advanced ovarian carcinoma.

  1986cites this paper
• A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.

  1986cites this paper
• Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.

  1985cites this paper
• [Prognostic factors of ovarian cancer].

  1985cites this paper
• Erfahrungen mit CA 125, einem Tumormarker für maligne epitheliale Ovarialtumoren*

  1985cites this paper
• Prognostic significance of morphology of tumor and retroperitoneal lymph nodes in epithelial carcinoma of the ovary. I. Correlation with lymph node metastasis.

  1984cites this paper
• Prognostic significance of morphology of tumor and retroperitoneal lymph nodes in epithelial carcinoma of the ovary. II. Correlation with survival.

  1984cites this paper
• Prognostic significance of morphology of tumor and retroperitoneal lymph node in epithelial carcinoma of the ovary

  1984cites this paper
• [The significance of clinical and morphological parameters for the prognosis of granulosa cell tumors of the ovaries].

  1984cites this paper
• Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary.

  1984cites this paper
• Characterization and Survival of Patients With Serous Cystadenocarcinoma of the Ovaries

  1984cites this paper
• [Radiotherapy of ovarian carcinoma].

  1984cites this paper
• [Prognostic significance of morphological parameters in malignant epithelial ovarian tumors].

  1983cites this paper
• Neoplasia in the Vagina Following Hysterectomy for Dysplasia or Carcinoma in Situ of the Uterine Cervix

  1983cites this paper
• The role of the radiation oncologist in the management of gynecologic cancer

  1983cites this paper
• Ovarian Epithelial Tumors of Low Malignant Potential: A Review

  1983cites this paper
• Importance of Histologic Grading in the Prognosis of Epithelial Ovarian Carcinoma

  1982cites this paper
• Histologic correlates of virulence in ovarian adenocarcinoma. I. Effect of differentiation.

  1982cites this paper
• Die Untersuchung von Tumorgewebe als Basis der Therapieplanung beim Ovarialkarzinom und ihre klinischen Konsequenzen

  1982cites this paper
• Regional behavioral variations of epidermoid carcinoma of the head and neck: A study in an animal model

  1982cites this paper
• II. Morphologic correlates of host response

  1982cites this paper
• Hiiufigkeit uod Epidemiologie

  1982cites this paper
• Histologic correlates of virulence in ovarian adenocarcinoma. II. Morphologic correlates of host response.

  1982cites this paper
• Histologic correlates of virulence in ovarian adenocarcinoma

  1982cites this paper
• The Identification and Prognosis of Borderline Epithelial Tumors

  1982cites this paper
• Prognostic importance of psammoma bodies in adenocarcinomas of the ovaries.

  1982cites this paper
• [Clinical aspects and therapy in primary ovarian cancer].

  1982cites this paper
• Prognostic Factors in Carcinoma of the Cervix

  1982cites this paper
• [Serous and mucinous ovarian cystadenomas at the limit of malignancy].

  1980cites this paper
• Correlations between tumor antigenicity, malignant potential, and local host immune response.

  1980cites this paper
• Advanced ovarian cancer: correlation of histologic grade with response to therapy and survival.

  1980cites this paper
• Radiation therapy in stage II ovarian carcinoma. The influence of histologic grade

  1980cites this paper
• Advanced ovarian cancer correlation of histologic grade with response to therapy and survival

  1980cites this paper
• Duct elastosis in infiltrating carcinoma of the breast.

  1979cites this paper
• Cancer of the ovary.

  1979cites this paper
• Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future.

  1979cites this paper
• Local responses in primary and secondary human lung cancers. I. Patterns of cellular (eosinophils and macrophages) and extracellular (acid mucopolysaccharide) reactions.

  1979cites this paper
• The pathological assessment of ovarian neoplasms. III: The malignant "epithelial" tumours.

  1979cites this paper